How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | EMREMERSON ELECTRIC CO | 3665.TW3665.TW | VRTVertiv Holdings Co | AMEAMETEK INC/ | Median of the restexcluding EMR |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $160.29▼ 2.82 (1.73%) | NT$1875.00▼ 100.00 (5.06%) | $195.59▼ 16.56 (7.81%) | $247.36▲ 0.14 (0.06%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 9.0/10 | 10.0/10 | 10.0/10 | 9.0/10 | 10.0/10 |
| Market value | $90.21B | $365.55B | $74.82B | $56.65B | |
| Revenue | $18.02B | $71.25B | $10.23B | $7.40B | |
| Profit | $2.29B | $9.01B | $1.33B | $1.48B | |
| Revenue growthChange in sales versus the prior year. | 3.0% | 31.7% | 27.7% | 6.6% | 27.7% |
| Gross marginShare of sales left after the direct cost of producing them. | 52.8% | 31.7% | 36.3% | 36.0% | 36.0% |
| Operating marginShare of sales left after running the business, before interest and tax. | — | 17.5% | 17.9% | 25.8% | 17.9% |
| Profit marginProfit kept from each dollar of sales. | 12.7% | 12.6% | 13.0% | 20.0% | 13.0% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 14.8% | 6.8% | 18.5% | 22.6% | 18.5% |
| Return on equityProfit against the owners' stake in the company. | 11.3% | 19.3% | 33.8% | 13.9% | 19.3% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | 19.4% | 27.3% | 12.6% | 19.4% |
| P/E ratioPrice paid per dollar of annual profit. | 39.34x | 40.59x | 56.14x | 38.27x | 40.59x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | 24.46x | 35.55x | 28.44x | 28.44x |
| Price to book | 4.45x | 7.84x | 18.98x | 5.33x | 7.84x |
| Debt to equityTotal liabilities compared with owners' stake. | 1.07x | 0.76x | 2.10x | 0.51x | 0.76x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 7/9 | 6/9 | 6/9 | 7/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | not reported | safe | safe | safe |
How EMR compares with the others
- EMR's profit margin of 12.7% is in line with the median of the other companies selected (13.0%).
- Its revenue grew more slowly than the median of the other companies selected: 3.0% against 27.7%.
- It trades at a P/E in line with the median of the other companies selected (39.3x against 40.6x).
- Its liabilities are higher relative to equity than the median of the other companies selected: 1.1x against 0.8x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.